Copyright 2025
Medical Security Card Company, LLC
All Rights Reserved
We take the privacy of your personal information seriously. By signing up I agree to WellRx's terms of use and privacy policy.
IVOSIDENIB (EYE voe SID e nib) targets proteins in cancer cells and stops the cancer cells from growing. It treats acute myelogenous leukemia and cholangiocarcinoma.
Ivosidenib 250mg, Oral tablet
Grapefruit juice
· Severity: Major
· Notes for Consumers: Do not ingest Grapefruit or Grapefruit Juice while on Ivosidenib therapy. Side effects from Ivosidenib may get worse if you take Grapefruit Juice or grapefruit-containing foods. Contact your prescriber immediately if you experience chest pain, dizziness, fainting or falling spells, palpitations, shortness of breath, or a change in your heartbeat (such as a fast or irregular heartbeat).
· Notes for Professionals: Advise patients to avoid grapefruit juice while taking ivosidenib due to increased plasma concentrations of ivosidenib, which increases the risk of QT prolongation or other toxicities. Ivosidenib is a CYP3A4 substrate and grapefruit juice is a strong CYP3A4 inhibitor. Coadministration with another strong CYP3A4 inhibitor increased ivosidenib single-dose AUC to 269% of control, with no change in Cmax.
You need to log into the site to use this feature
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Manufacturer Coupons and Offers Available
Number of Uses:
tibsovo
250 MG | Tablet | 60 tablets
You need to log into the site to use this feature
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
You will be redirected to your program in 5 seconds.
Our Terms and Conditions and Privacy Policy have recently been updated.
By declining you will be logged out of your account